New vaccine ‘could rejuvenate aging immune systems to tackle cancer and dementia’ (opens original article in a new tab)

Scientists are testing a new vaccine to rejuvenate the immune system by targeting worn-out T-cells in a first-in-human clinical trial, aiming to combat diseases like cancer, HIV, and dementia.

• Scientists are testing a new vaccine to rejuvenate the immune system by targeting worn-out T-cells in a first-in-human clinical trial.
• The vaccine, developed by SenTcell and Dr Alessio Lanna, aims to restore immune function to combat diseases like cancer, HIV, and dementia.
• Researchers will investigate if rejuvenated CD4+ T cells can release telomere-containing structures to improve overall health and immune response.